Bodhi Tree Biotechnology Inc Financial Summary

Quick Answer

Bodhi Tree Biotechnology Inc reported Total Revenue of $17.0 thousand for fiscal year 2025.

Bodhi Tree Biotechnology Inc — Key Financials by Year

Metric 2025 2024
Total Revenue $17.0K
Net Income -$149.7K
Diluted EPS -$0.01
Total Assets $119.2K
-55.8%
$269.3K
Stockholders Equity $119.2K
-55.7%
$268.8K
Operating Income -$147.6K
Shares Outstanding 25.44M
+0.0%
25.44M

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $0.00 -100.0% -100.0%
Net Income December 31, 2025 -$52.9K +18.3% -154.9%
Diluted EPS December 31, 2025 -$0.01
Total Assets December 31, 2025 $69.7K -41.5%
Stockholders Equity December 31, 2025 $66.2K -67.6% -44.4%
Operating Income December 31, 2025 -$52.9K +18.3% -165.1%
Shares Outstanding December 31, 2025 25.44M +0.0%
  • Bodhi Tree Biotechnology Inc reported Total Revenue of $17.0 thousand for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc reported Net Income of -$149.7 thousand for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc reported Total Assets of $119.2 thousand for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc showed a decrease of -55.8% in Total Assets compared to the prior fiscal year.
  • Bodhi Tree Biotechnology Inc reported Stockholders Equity of $119.2 thousand for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc showed a decrease of -55.7% in Stockholders Equity compared to the prior fiscal year.
  • Bodhi Tree Biotechnology Inc reported Operating Income of -$147.6 thousand for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc reported Shares Outstanding of 25.44 million shares for fiscal year 2025.
  • Bodhi Tree Biotechnology Inc showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment